Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
There's the link for you https://www.linkedin.com/posts/crenguta-strimbeanu-dinu-82702a37_primerdesign-launches-coronavirus-qpcr-pathogen-activity-6635804793291980801-7Y1F
Mmm so much action here that the board missed my message?. interesting...
Just read a report of a case in South Korea without travel to China nor known contact with an infected person, this means the virus is clearly out of control and the quarantines have failed. Now, IMHO the SP won't move much until there's some kind of news from the FDA.
From the RNS:
"""
MED3000 is now the codename for a formulation of DermaSys developed specifically for the treatment of ED that, we now believe, works through an evaporative and unique mode of action which is subject to a new patent application. Initial Company assessments indicate MED3000's combination of volatile solvent components creates an evaporative and novel action that stimulates nerve sensors in the highly innervated glans ***** rapidly, leading to smooth muscle relaxation, tumescence and erection.
"""
This is what I was looking for, DermaSys works in an unexpected way. They might be onto something important here
Sad to see you leave, bears are specially annoying on this forum. They might think the same of bulls, who knows. Anyway, no point in wasting time reading posts from interested parties. Company results will speak for themselves for better or worse.
DermaSys also beat Vitaros, which in turn beat an inert placebo yet the company is not giving us news regarding whether they'll try to market dermasys as it is now in the form of a non prescription drug or trial it against a true inert substance
seems the Purch acquisition was in 2018, not 2015
https://www.futureplc.com/2018/07/18/future-to-gain-us-market-leadership-with-proposed-acquisition-of-purchs-consumer-division/